Eisai
4523.T
#1780
Rank
HK$72.89 B
Marketcap
HK$258.43
Share price
0.57%
Change (1 day)
-37.68%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2023 (TTM): HK$17.10

According to Eisai's latest financial reports the company's current EPS (TTM) is HK$16.97. In 2022 the company made an earnings per share (EPS) of HK$12.46 a decrease over its 2021 EPS that were of HK$55.31.

EPS history for Eisai from 2009 to 2023

Annual EPS

Year EPS Change
2023 (TTM)HK$17.1037.22%
2022HK$12.46-77.48%
2021HK$55.31-41.88%
2020HK$95.17-0.94%
2019HK$96.0752.59%
2018HK$62.96124.17%
2017HK$28.09-49.42%
2016HK$55.5337.08%
2015HK$40.51-11.75%
2014HK$45.90-3.23%
2013HK$47.44-18.56%
2012HK$58.25-15.51%
2011HK$68.95-3.75%
2010HK$71.64-1.36%
2009HK$72.62